CHRISTINA CHUMLEY: Open Payments
NPI 1043640659 · PROVIDENCE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,211 in 75 payments from 15 companies in 2025. Trend: 2023 $675 · 2024 $947 · 2025 $1,211
Food & beverage: $1,211
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $314 |
| Amgen Inc. | 14 | $147 |
| AstraZeneca Pharmaceuticals LP | 5 | $143 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $122 |
| Novo Nordisk Inc | 6 | $91 |
| PFIZER INC. | 5 | $80 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $68 |
| Otsuka America Pharmaceutical, Inc. | 3 | $67 |
| Lilly USA, LLC | 3 | $50 |
| Exact Sciences Corporation | 3 | $48 |
Products named: QULIPTA, UBRELVY, CAPLYTA, AIRSUPRA, OTEZLA, XIFAXAN, VRAYLAR, Cologuard Collection Kit.
Industry payments across KY — which companies pay providers there.
